(1S,7aα,11aβ,11bα,13aα)-Hexadecahydro-4β-methyl-12β,1β,5aβ-ethanylylidene-5aH-naphtho[1,2-c]quinolizine-7α,15-diol
![(1S,7aα,11aβ,11bα,13aα)-Hexadecahydro-4β-methyl-12β,1β,5aβ-ethanylylidene-5aH-naphtho[1,2-c]quinolizine-7α,15-diol price.](/CAS/20180808/GIF/16585-08-3.gif)
|
- $201 - $880
- Product name: (1S,7aα,11aβ,11bα,13aα)-Hexadecahydro-4β-methyl-12β,1β,5aβ-ethanylylidene-5aH-naphtho[1,2-c]quinolizine-7α,15-diol
- CAS: 16585-08-3
- MF: C20H31NO2
- MW: 317.47
- EINECS:
- MDL Number:
- Synonyms:(1S,7aα,11aβ,11bα,13aα)-Hexadecahydro-4β-methyl-12β,1β,5aβ-ethanylylidene-5aH-naphtho[1,2-c]quinolizine-7α,15-diol;Himgaline;12,1,5a-Ethanylylidene-5aH-naphtho[1,2-c]quinolizine-7,15-diol, hexadecahydro-4-methyl-, (1R,4S,5S,5aS,7R,7aR,11aS,11bS,12S,13aR,15R)-;(–)-Himgaline;(1S,7aα,11aβ,11bα,13aα)-Hexadecahydro-4β-methyl-12β,1β,5aβ-ethanylylidene-5aH-naphtho[1,2-c]quinolizine-7α,15-diol
3 prices
Selected condition：
Brand
- AK Scientific
- Cayman Chemical
Package
- 500μg
- 2.5mg
- ManufacturerAK Scientific
- Product number4625ED
- Product descriptionHimgaline
- Packaging2.5mg
- Price$880
- Updated2021-12-16
- Buy
- ManufacturerCayman Chemical
- Product number29990
- Product description(–)-Himgaline
- Packaging500μg
- Price$201
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number29990
- Product description(–)-Himgaline
- Packaging2.5mg
- Price$702
- Updated2024-03-01
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 4625ED | Himgaline | 2.5mg | $880 | 2021-12-16 | Buy |
| Cayman Chemical | 29990 | (–)-Himgaline | 500μg | $201 | 2024-03-01 | Buy |
| Cayman Chemical | 29990 | (–)-Himgaline | 2.5mg | $702 | 2024-03-01 | Buy |
Properties
Boiling point :476.4±35.0 °C(Predicted)
Density :1.26±0.1 g/cm3(Predicted)
pka :15.09±0.60(Predicted)
form :A solid
Density :1.26±0.1 g/cm3(Predicted)
pka :15.09±0.60(Predicted)
form :A solid
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|